How the new Patent Trial and Appeal Board rules impact the practice of inter partes reviews

被引：0
|
作者：
Hsing, Benjamin C. [1 ]
French-Brown, Wanda [1 ]
机构：
[1] BakerHostetler LLP, 45 Rockefeller Plaza, New York, NY 10111 USA
来源：
PHARMACEUTICAL PATENT ANALYST | 2016年 / 5卷 / 05期
关键词：
inter partes review; IPR; Patent Trial and Appeal Board; PTAB;
D O I：
10.4155/ppa-2016-0020
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：281 / 283
页数：3
相关论文
共 27 条
  • [21] Special Session - New Engineering Stories: How Feminist Thinking Can Impact Engineering Ethics and Practice
    Tucker, Jessica
    Pawley, Alice
    Riley, Donna
    Catalano, George
    FIE: 2008 IEEE FRONTIERS IN EDUCATION CONFERENCE, VOLS 1-3, 2008, : 925 - 927
  • [22] Standing on Their Own Two Feet: How the New Public Charge Rules Could Impact Non-European LPR Applicants
    Lowrey, Kendal
    Van Hook, Jennifer
    POPULATION RESEARCH AND POLICY REVIEW, 2022, 41 (02) : 559 - 582
  • [23] Standing on Their Own Two Feet: How the New Public Charge Rules Could Impact Non-European LPR Applicants
    Kendal Lowrey
    Jennifer Van Hook
    Population Research and Policy Review, 2022, 41 : 559 - 582
  • [24] India's Clinical Trial Regulatory Changes, Indian Researcher's Awareness of Recently Changed Regulations, and the Impact of the New Drugs and Clinical Trial Rules: A Review
    Vennu, V.
    Saini, P. P.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 82 (05) : 726 - 740
  • [25] Where does capillary blood glucose stand following the IMPACT trial? Implications of a new way of measuring glucose in routine clinical practice
    Aguilera, Eva
    Vazquez, Federico
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2017, 64 (03): : 125 - 127
  • [26] The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: A cluster randomised controlled trial and qualitative investigation
    Wells, Sue
    Rafter, Natasha
    Kenealy, Timothy
    Herd, Geoff
    Eggleton, Kyle
    Lightfoot, Rose
    Arcus, Kim
    Wadham, Angela
    Jiang, Yannan
    Bullen, Chris
    PLOS ONE, 2017, 12 (04):
  • [27] How do the UK public interpret COVID-19 test results? Comparing the impact of official information about results and reliability used in the UK, USA and New Zealand: a randomised controlled trial
    Recchia, Gabriel
    Schneider, Claudia R.
    Freeman, Alexandra L. J.
    BMJ OPEN, 2021, 11 (05):
123